Advancing Care for Patients With Resectable NSCLC

Advances in immunotherapy, targeted therapy, and biomarker-driven treatment strategies are transforming the management of resectable non–small cell lung cancer (NSCLC). During JADPRO Live 2024, presenters discussed the latest advancements in perioperative and adjuvant therapies, biomarker testing, and future directions in NSCLC treatment.

Authors

Danielle Fournier

Institutions

The University of Texas MD Anderson Cancer Center (US)

Publication Details

Journal: Journal of the Advanced Practitioner in Oncology
Published: 2025-03-25
DOI: https://doi.org/10.6004/jadpro.2025.16.2.13
Primary Topic: Multiple and Secondary Primary Cancers
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Advancing Care for Patients With Resectable NSCLC

Danielle Fournier

Mar 25, 2025

Journal of the Advanced Practitioner in Oncology

Multiple and Secondary Primary Cancers

article

Advancing Care for Patients With Resectable NSCLC

Danielle Fournier

March 25, 2025article en

Abstract

Journal of the Advanced Practitioner in OncologyVol. 16(2)

The University of Texas MD Anderson Cancer Center (US)

Openalex Percentile: Top 91%

Multiple and Secondary Primary Cancers

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Advancing Care for Patients With Resectable NSCLC — Danielle Fournier · Journal of the Advanced Practitioner in Oncology (2025) | TGRS Research Map | TGRS